Is CONMED Corporation (CNMD) overvalued? · P/E 19, rev $1.31B
CONMED Corporation (CNMD) is a medical devices company listed on NYSE.
This page asks whether CONMED Corporation (CNMD) looks expensive on cached numbers — not a short thesis.
Latest reported CNMD revenue for 2024-12-31 was $1.31B. Net income was $132.4M. Revenue was up 5.0% from 2023-12-31 to 2024-12-31. CNMD currently screens at market cap $1.04B and trailing P/E 19.3.
CNMD currently screens at market cap $1.04B and trailing P/E 19.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CNMD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CNMD stock page for the full model, not this heading.
Not investment advice.